Aclarion, Inc.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
ACON$1.60-8.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Changes in Stockholders' Equity (Deficit)
| Series B · Series C | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock · Preferred Stock · Common Stock · Paid-In · Accumulated | ||||||||||
| Shares · Value · Shares · Value · Shares · Value · Capital · Deficit · Total | ||||||||||
| For the Three Months Ended December 31, 2025 | ||||||||||
| Balance, December 31, 2024 | 930 | $– | 874 | $– | 1,370 | $ | * | $52,232,368 | $(51,262,311) | $970,057 |
| Share-based compensation | – | – | – | – | – | – | 55,897 | – | 55,897 | |
| Registered direct offerings of common stock | – | – | – | – | 19,144 | * | 5,167,927 | – | 5,167,927 | |
| Public offering of common stock and warrants | – | – | – | – | 16,048 | * | 14,554,545 | – | 14,554,545 | |
| Common stock issuance costs | – | – | – | – | – | – | (2,101,282) | – | (2,101,282) | |
| Redemption of Series B preferred stock | (930) | – | – | – | – | – | (1,213,590) | – | (1,213,590) | |
| Conversion of C-series preferred stock to common stock | – | – | (874) | – | 687 | * | – | – | – | |
| Exercise of C-series warrants | – | – | – | – | 629 | * | 336,441 | – | 336,441 | |
| Warrant amendment | – | – | – | – | – | – | 48,087 | – | 48,087 | |
| Alternative cashless exercise of B warrants | – | – | – | – | 544,299 | 5 | (5) | – | – | |
| Round-up conversion related to reverse stock splits | – | – | – | – | 161 | * | (1) | – | (1) | |
| Net loss | – | – | – | – | – | – | – | (2,037,436) | (2,037,436) | |
| Balance, March 31, 2025 | – | $– | – | $– | 582,338 | $6 | $69,080,387 | $(53,299,747) | $15,780,645 | |
| For the Three Months Ended March 31, 2026 | ||||||||||
| Balance, December 31, 2025 | – | $– | – | $– | 854,371 | $9 | $71,331,048 | $(58,495,940) | $12,835,117 | |
| Share-based compensation | – | – | – | – | – | – | 4,694 | – | 4,694 | |
| Registered direct offerings of common stock | – | – | – | – | 200,000 | 2 | 1,035,998 | – | 1,036,000 | |
| Proceeds from direct offering of prefunded warrants | – | – | – | – | – | – | 9,323,982 | – | 9,323,982 | |
| Exercise of prefunded warrants | – | – | – | – | 1,390,500 | 14 | (14) | – | – | |
| Common stock issuance costs | – | – | – | – | – | – | (691,739) | – | (691,739) | |
| Net loss | – | – | – | – | – | – | – | (2,853,575) | (2,853,575) | |
| Balance, March 31, 2026 | – | $– | – | $– | 2,444,871 | $25 | $81,003,969 | $(61,349,515) | $19,654,479 | |
| * | Rounds to less than one share |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.